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RESEARCH ARTICLE
Resistance to ectromelia virus infection
requires cGAS in bone marrow-derived cells
which can be bypassed with cGAMP therapy
Eric B. WongID
¤, Brian Montoya, Maria FerezID, Colby Stotesbury, Luis J. SigalID*
Thomas Jefferson University, Department of Microbiology and Immunology, Philadelphia, Pennsylvania,
United States of America




Cells sensing infection produce Type I interferons (IFN-I) to stimulate Interferon Stimulated
Genes (ISGs) that confer resistance to viruses. During lympho-hematogenous spread of the
mouse pathogen ectromelia virus (ECTV), the adaptor STING and the transcription factor
IRF7 are required for IFN-I and ISG induction and resistance to ECTV. However, it is
unknown which cells sense ECTV and which pathogen recognition receptor (PRR)
upstream of STING is required for IFN-I and ISG induction. We found that cyclic-GMP-AMP
(cGAMP) synthase (cGAS), a DNA-sensing PRR, is required in bone marrow-derived
(BMD) but not in other cells for IFN-I and ISG induction and for resistance to lethal mouse-
pox. Also, local administration of cGAMP, the product of cGAS that activates STING, res-
cues cGAS but not IRF7 or IFN-I receptor deficient mice from mousepox. Thus, sensing of
infection by BMD cells via cGAS and IRF7 is critical for resistance to a lethal viral disease in
a natural host.
Author summary
During primary acute systemic viral infections, cells sensing virus through Pathogen Rec-
ognition Receptors (PRR) can produce Type I interferons (IFN-I) to induce an anti-viral
state that curbs viral spread and protect from viral disease. The dissection of the specific
cells, receptors and downstream pathways required for IFN-I production during viral
infection in vivo is necessary to improve anti-viral therapies. In this study, we demonstrated
that the cytosolic PRR cGAS in hematopoietic cells but not in parenchymal cells is required
for protection against ectromelia virus, the archetype for viruses that spread through the
lympho-hematogenous route. We also show that cGAS deficiency can be bypassed by local
administration of cyclic-GMP-AMP (cGAMP) by inducing IFN-I only in the skin and in
the presence of virus. Our study provides novel insights into the cGAS signaling pathway
and highlights the potential of cGAMP as an efficient anti-viral treatment.
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Introduction
Numerous viruses relevant to human and animal health utilize a lympho-hematogenous route
of dissemination whereby they penetrate their hosts though disruptions of epithelial surfaces
such as the skin, spread to the draining lymph node (dLN) via afferent lymphatics, and become
systemic by disseminating to the blood through efferent lymphatics [1]. However, our under-
standing of how the host innate immune system mechanistically induces protective resistance
to the virus during lympho-hematogenous dissemination is incomplete. Ectromelia virus
(ECTV), a member of the Orthopoxvirus genus of large, closely-related DNA viruses and the
causative agent of mousepox (the mouse homolog of human smallpox) is the archetype used to
study lympho-hematogenous dissemination [1–4].
Type I interferons (IFN-I), which in the mouse, include one IFN-β and 14 IFN-α, are pro-
duced rapidly following viral infection. IFNs induce a Janus kinase signal transducer and acti-
vator of transcription-mediated (JAK-STAT) pathway that leads to the transcriptional
regulation of several hundred interferon stimulated genes (ISGs) that are collectively involved
in the coordinated effort to resist and control viral spread and pathogenicity [5–7]. Two lines
of evidence demonstrate the importance of IFN-I in resistance to mousepox. First, C57BL/6(B6)
mice are resistant to mousepox, but B6 mice deficient in the IFN-I receptor (IFNAR) subunit
IFNAR1 have very high levels of viral replication, dissemination and succumb to mousepox
[8–10]. Second, ECTV encodes EVM166, a IFN-I decoy receptor, that is critical for ECTV vir-
ulence in susceptible mice but is still pathogenic in IFNAR1 deficient mice [9]. Notably,
EVM166 inactivates mouse IFNα but not IFNβ suggesting that only IFNα is critical for resis-
tance to mousepox [9].
The production of IFN-I, and also of many inflammatory cytokines and chemokines,
requires sensing of infection through pathogen recognition receptors (PRR) [11–14]. PRRs are
a class of germline-encoded receptors that recognize pathogen-associated molecular patterns
(PAMP), typically conserved molecular motifs with repetitive structures such as lipopolysac-
charide, RNA and DNA [11]. PAMPs in the cell microenvironment are surveyed by mem-
brane bound PRRs that are either at the cell surface or on endocytic compartments, such as
Toll-like receptor 9 (TLR9) which recognizes viral CpG DNA. The cytosolic TIR domain of
TLR9 and most other TLRs directly interact with the adapter Myeloid differentiation primary
response 88 (MyD88) which becomes phosphorylated upon PAMP sensing. This activates a
cascade of signaling molecules that culminates in the activation of transcription factors such as
IRF3, IRF7, and NF-κB that induce the transcription of IFN-I and/or proinflammatory cyto-
kines and chemokines. PRRs in in the cytoplasm such as RIG-I like helicases (RLH) recognize
viral RNA, while Interferon-activated gene 204 (Ifi204, IFI16 in humans), and cyclic-GMP-
AMP (cGAMP) synthase (cGAS) recognize viral DNA [12–15]. cGAS synthesizes the messen-
ger cGAMP which bind Stimulator of Interferon Genes (STING) to induce IRF3, IRF7, NF-κB
or other transcription factors to stimulate the transcription of IFN-I and chemokines and
cytokines [12]. Ifi204/IFI16 also works through STING but the specific mechanism is not
understood.
We have previously demonstrated cooperation between sensing pathways in response to
ECTV, in which MHC-IIhi dendritic cells (DCs) from the skin migrate to the dLN and produce
the chemokines CCL2 and CCL7 in a TLR9-MyD88-IRF7 dependent manner to recruit
inflammatory monocytes (iMO) to the dLN [16,17]. We also showed that in the dLN iMOs
become infected and use STING-IRF7 and STING-NF-κB to respectively induce IFNα and
IFNβ [16]. We also showed that during lympho-hematogenous ECTV spread, iMOs and not
plasmacytoid DCs (pDCs) are the main producers of IFN-I. Yet, the PRR(s) responsible for
IFN-I induction upstream of STING remained unidentified. Very recently, Cheng et al.
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showed that cGAS upstream of STING is important for IFNβ production and resistance to
mousepox with high ECTV doses [18] but its role in the induction of the more critical IFNα or
ISGs and the in vivo cellular requirements were not investigated. Here we confirm that cGAS
is necessary for resistance to mousepox, in our case to relatively low viral doses, and that it
is important for efficient IFNβ expression. We also demonstrate that cGAS is important for
optimal expression of more relevant IFNα and also ISGs. Furthermore, we demonstrate that
resistance to mousepox necessitates cGAS in bone marrow-derived (BMD) cells but not in
parenchymal cells. We further show that cGAMP administration at the site of infection pre-
vents lethal mousepox in cGAS deficient mice by curbing virus spread through the induction
of IFN-I and ISGs. Mechanistically, cGAMP rescue requires the transcription factor IRF7 and
the IFN-I receptor IFNAR1. Together, these findings demonstrate that early sensing of virus
by BMD cells via cGAS is critical to control a highly pathogenic DNA viral infection, and high-
lights the importance that curbing virus spread from the initial site of infection.
Methods
Mice
All mice used in experiments were 6–12 weeks old. C57BL/6 (B6) mice were purchased from
Charles River. Cgas-/- mice were a gift from Zhijian Chen (UT Southwestern Medical Center,
Dallas TX). Tmem173gt (C57BL/6J-Tmem173gt/J) were originally purchased from Jackson Lab-
oratories (Bar Harbor, ME). Irf7-/- (B6.129P2-Irf7tm1Ttg/TtgRbrc) were from Riken Biore-
source Center (Tsukuba, Japan). Ifnar1-/- mice backcrossed to B6 were a gift from Dr. Thomas
Moran (Mount Sinai School of Medicine, New York, NY). Ifi204-/- mice were generated from
frozen germplasm from the Knockout Mouse Project (KOMP) Repository (UC Davis, Davis
CA). Colonies were bred at Thomas Jefferson University under specific pathogen free
conditions.
Viruses and infection
Virus stocks, including ECTV-Moscow strain (WT) (ATCC VR-1374), ECTV-EGFP [19] and
ECTV-dsRED [20] were propagated in tissue culture as previously described [9]. Mice were
infected with 3,000 plaque forming units (PFUs) ECTV-WT, ECTV-EGFP or ECTV-dsRED
as indicated. For the determination of survival, mice were monitored daily and to avoid unnec-
essary suffering, mice were euthanized and counted as dead when imminent death was certain
as determined by lack of activity and unresponsiveness to touch. Euthanasia was according to
the 2013 edition of the AVMA Guideline for the Euthanasia of Animals. For virus titers, the
entire spleen or portions of the liver were homogenized in RPMI using a Tissue Lyser (QIA-
GEN). Virus titers were determined on BSC-1 cells as described before [9].
Production of bone marrow chimeric mice
Bone marrow chimeras were prepared as previously described [21]. Briefly, 6- to 8-week-old
mice were irradiated with 900 rads using a GammaCell 40 apparatus (Nordion Inc.). Irradiated
mice were reconstituted intravenously with an inoculation of 2-5x106 bone marrow cells from
different donors. Chimeras were administered with acidified water and rested for 8 weeks after
reconstitution.
cGAMP administration
To investigate the effect of exogenous cGAMP during infection, 10 ug of 2’3’ cGAMP (Invivo-
gen) or control PBS was injected into the footpad 4 hours prior to infected with ECTV.
cGAS in hematopoietic cells mediates resistance to viral disease
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Flow cytometry
Flow cytometry was performed as previously described [9]. The following Abs were used:
BV785-CD3ε (Clone 145-2C11), BV711-CD8α (Clone 53–6.7), APC/Cy7-CD11b (Clone M1/
70), BV-421-Gr-1 (Clone RB6-8C5), PE/Cy7-CD11c (Clone N418), FITC-CD45 (Clone I3/
2.3), PerCP/Cy5.5-IAb (Clone AF6-120.1), BV605-NK1.1 (PK136) were from Biolegend.
BUV395-CD4 (Clone GK1.5) and BUV395-CD19 (Clone 1D3) were from BD Biosciences. To
obtain single-cell suspensions, LNs were first incubated in Liberase TM (1.67 Wünsch units/
mL) (Sigma) in PBS with 25 mM HEPES for 30 min at 37˚C before adding PBS with 25 mM
HEPES + 10% FBS to halt the digestion process, followed by mechanical disruption of the tis-
sue through a 70-μm filter. Cells were washed once with FACS buffer (PBS with 1% BSA +
0.1% sodium azide) before surface staining. For analysis, samples were acquired using either a
BD LSR II flow cytometer or a BD Fortessa flow cytometer (BD Biosciences), and data were
analyzed with FlowJo software (TreeStar). For cell sorting, samples were acquired with a BD
FACS Aria III sorter (BD Bioscience).
RNA preparation and RT-qPCR
Total RNA from LNs or sorted cells (104−105 cells) was obtained with the RNeasy Mini Kit
(QIAGEN) as previously described [10,16]. First-strand cDNA was synthesized with High
Capacity cDNA Reverse Transcription Kit (Life Technologies). qPCR was performed as before
[10,16] using primers as follows: Gapdh: tgtccgtcgtggatctgac and cctgcttcaccaccttcttg, Evm003:
tctgtcctttaacagcatagatgtaga and tgttaactcggaagttgatatggta, Evm036: tgccagttagcactgcgtat and
aggtgttctggagaatcaaaga, Ifng: gcaaaaggatggtgacatga and ttcaagacttcaaagagtctgaggta, Ccl2: catc-
cacgtgttggctca and gatcatcttgctggtgaatgagt, Ccl7: ttgacatagcagcatgtggat and ttctgtgcctgctgctcata,
Cxcl9: cttttcctcttgggcatcat and gcatcgtgcattccttatca, Il6: tctaattcatatcttcaaccaagagg and tggtcctta
gccactccttc, Tnf: tcttctcattcctgcttgtgg and ggtctgggccatagaactga, Mx1: gatccgacttcacttccagatgg
and catctcagtgtagtcaaccc, Il12: gactccaggggacaggcta and ccaggagatggttagcttctg, Ifit3: tgaactgct-
cagcccaca and tcccggttgacctcactc, Isg15: agtcgacccagtctctgactct and ccccagcatcttcaccttta, Irf7:
tgtagtgtggtgacccttgc and cttcagcactttcttccgaga, Ifnb1: catttccgaatgttcgtcct and cacagccctctccatc
aacta, Ifna4: gtcttttgatgtgaagaggttcaa and tcaagccatccttgtgctaa, Ifna-non4: aagctgtgtgatgcaacag
gt and ggaacacagtgatcctgtgg.
Statistics
Data were analyzed with Prism 6 software (GraphPad Software). For survival we used the Log-
rank (Mantel-Cox). For other experiments ANOVA with Tukey correction for multiple com-
parisons or Student’s t test were used as applicable. In all figures, �p<0.05, ��p<0.01,
���p<0.001, ����p<0.001.
Ethics statement
All the procedures involving mice were carried out in strict accordance with the recommenda-
tions in the Eight Edition of the Guide for the Care and Use of Laboratory Animals of the
National Research Council of the National Academies. All experiments were approved by
Thomas Jefferson University’s Institutional Animal Care and Use Committee under protocol
number 01727 “Immune Control of Viral Infections”.
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Results
cGAS, but not IFI204, is not required for resistance to ECTV infection
Our previous work established the important role of STING, IRF7 and NF-κB in IFN-I induc-
tion during ECTV lympho-hematogenous dissemination [16]. We had also explored a possible
role for the DNA-dependent activator of IFN-regulator factors (DAI/Zbp1) as the PRR
upstream of STING, but we found it was not required for resistance to ECTV or IFN-I induc-
tion [16]. Thus, we set to identify the PRR upstream of STING. Ifi204 is one of the few genes
that mapped as a possible candidate to the still unidentified Resistance to Mousepox 4 (Rmp-
4) gene [22]. Notably, murine IFI204 and its human ortholog IFI16 are members of the PRR
AIM2-like receptor family and have been shown to signal through STING [23–26]. This made
Ifi204 an intriguing candidate as an ECTV PRR. However, all Ifi204-/- mice survived ECTV
infection (Fig 1A) and did not exhibit significant differences with WT B6 mice in viral
Fig 1. cGAS, but not IFI204, is required for optimal resistance to ECTV infection. (A) Survival of the indicated mice. (B)
Expression of Evm036 in the dLN at 2 dpi of the indicated mice as determined by RT-qPCR. Data are displayed as mean ± SEM from
5 mice per group in one experiment, which is representative of two similar experiments. (C-D) Virus loads in the spleen (C) and
liver (D) of the indicated mice at 7 dpi as determined by plaque assay. Data are displayed as the mean ± SEM of 4–5 mice per
group. (E-G) Expression of IFN-I in the dLN at 2.5 dpi of the indicated mice as determined by RT-qPCR. Data are displayed as
mean ± SEM from 5 mice per group in one experiment, which is representative of three similar experiments. (H) Survival of the
indicated mice. (I-J) Expression of Evm036 in the skin (1 or 2 dpi) (I) and dLN (2 dpi) (J) of the indicated mice as determined by
RT-qPCR. Data are displayed as mean ± SEM from 5 mice per group in one experiment, which is representative of three similar
experiments. (K-L) Virus loads in the spleen (K) and liver (L) of the indicated mice at 3, 5 or 7 dpi as determined by plaque assay.
Data are displayed as the mean ± SEM of 5–6 mice per group. For all, �p<0.05, ��p<0.01, ���p<0.001, ����p<0.0001.
https://doi.org/10.1371/journal.ppat.1008239.g001
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replication in the dLN at 2.5 dpi, measured by reverse transcriptase quantitative polymerase
chain reaction (RT-qPCR) as mRNA for the ECTV gene Evm036 (Fig 1B). Also, while Ifi204-/-
mice had a slight but significantly higher virus titers in the spleen at 7 dpi, there were no signif-
icant differences in viral burden in the liver compared to B6 controls (Fig 1C and 1D). Further-
more, Ifi204-/- mice had similar levels of mRNA for Ifna-non4 (detected by RT-qPCR with a
single primer pair as mRNA for all IFN-α except α4 [27] and Ifnb1 (encoding the single IFN-
β) expression in the dLN compared to B6 mice (Fig 1E and 1G). Thus, IFI204 is not a signifi-
cant cytosolic PRR for IFN-I expression in response to ECTV infection or for ECTV control.
We investigated a possible role for cGAS, because it had been shown important for the con-
trol of the DNA virus herpes simplex-1 [28]. We found that most B6 mice deficient in cGAS
(Cgas-/-) succumbed to mousepox (Fig 1H). Consistently, viral loads, measured by Evm036
mRNA transcripts in the skin of the footpad at 1 and 2 dpi (Fig 1I) and in the dLN at 2 dpi (Fig
1J), were significantly higher in Cgas-/- mice compared to B6 controls. Furthermore, the unre-
stricted viral replication permitted swift dissemination to peripheral organs, as Cgas-/- mice
had significantly higher viral titers in the spleen at 3, 5 and 7 dpi (Fig 1K) and liver at 5 and 7
dpi (Fig 1L). Thus, cGAS is necessary for ECTV control and resistance to lethal mousepox.
Cgas-/- mice have a defective IFN-I and ISG response in the dLN after
infection
To determine whether cGAS deficiency affects IFN, chemokines, cytokines and ISG gene tran-
scription in the early innate immune response to ECTV during lympho-hematogenous spread,
we isolated mRNA from the dLN of infected B6 and Cgas-/- mice at 2.5 dpi and performed RT-
qPCR to measure relative fold-change in gene expression over each group’s contralateral
ndLN. We found that cGAS deficiency resulted in significantly decreased, but not absent, tran-
scription of the IFN-I genes Ifna4 (Fig 2A), Ifna-non4 (Fig 2B) and Ifnb1 (Fig 2C), which at
this time point are mostly produced by infected iMOs [16]. However, cGAS deficiency did not
affect IFN-γ gene expression (Fig 2D), which is produced mostly by NK cells [17,19,29]. Differ-
ent to WT mice, Cgas-/- mice did not upregulate expression of the ISGs Ifit3 (Fig 2E), Irf7 (Fig
2F) Isg15 (Fig 2G), and Mx1 (Fig 2H) suggesting that the induction of ISGs by IFN-I and IFN-
γ may be non-overlapping in vivo. To ensure that the significant decrease in IFN-I and ISG
expression is inherently due to cGAS deficiency and not a challenge-specific phenomenon, we
inoculated B6 and Cgas-/ mice with either ECTV or TLR9 agonist CpG and found that CpG
inoculation in the footpad does not induce IFN-I or ISG expression at 2 d post challenge (Il12
expression was used as a positive control and was found to be upregulated in both B6 and
Cgas-/- mice) (S1 Fig). cGAS deficiency did not affect the transcription of the chemokine genes
Ccl2 (Fig 2I) and Ccl7 (Fig 2J) that are important for iMO recruitment [16], or Cxcl9 (Fig 2K),
which is important for NK cell recruitment and dependent on IFN-γ during ECTV infection
[17]. Also, cGAS deficiency did not affect the transcription of the pro-inflammatory cytokine
genes Il12 (Fig 2L), Il6 (Fig 2M) and Tnf (Fig 2N). Together, these data suggest that the acceler-
ated viral dissemination and increased susceptibility of Cgas-/- mice to mousepox is likely due
to significantly reduced global IFN-I production in the dLN and consequently, a dampened
ISG response.
cGAS expression in hematopoietic-derived cells is required for optimal
IFN-I and ISG expression in the dLN
Next, we made bone marrow chimeras to investigate whether cGAS expression in the hemato-
poietic compartment is required for an optimal IFN-I response and resistance to ECTV. The
degree of donor BM reconstitution in the irradiated hosts was successful as there were
cGAS in hematopoietic cells mediates resistance to viral disease
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approximately equivalent cellularity and total numbers of different immune cell subsets in the
naïve contralateral LNs in all of the different groups (S2 Fig). We found that Cgas-/-!Cgas-/- and
Cgas-/-!B6 chimeras succumbed to mousepox, while B6! Cgas-/- and B6!B6 chimeras sur-
vived (Fig 3A). In agreement, compared to B6!B6 and B6!Cgas-/- mice, Cgas-/-!Cgas-/- and
Cgas-/-!B6 mice had significantly higher virus transcripts in the dLN at 2.5 dpi (Fig 3B) and
higher infectious virus in the spleen (Fig 3C) and liver (Fig 3D) at 7 dpi. This indicates that
ECTV control and resistance to mousepox requires cGAS expression in the hematopoietic com-
partment and not in the parenchyma. Accordingly, Cgas-/-!Cgas-/- and Cgas-/-!B6 chimeras
had significantly lower IFN-I expression in the dLN (Fig 3E–3G) but not Ifng (Fig 3H), Cxcl9
(Fig 3I), Il6 (Fig 3J), Il12 (Fig 3K) or Tnf (Fig 3L). Finally, cGAS expression in the hematopoietic
compartment was required for the expression of ISGs as Cgas-/-!Cgas-/- and Cgas-/-!B6 chime-
ras had significantly reduced levels of ISGs in the dLN at 2.5 dpi (Fig 3M–3P).
Cgas-/- mice have an intrinsic defect in IFN-I expression and accumulation
of MHC-IIhi DCs, iMOs and NK cells
We have shown that both MHC-IIhi DCs and iMOs are important sources of IFN-I in the
dLN after ECTV infection; MHC-IIhi DCs provide the early source of IFN-I in the dLN
Fig 2. Cgas-/- mice have a defective IFN-I and ISG response in the dLN after infection. (A-N) Expression of IFN-Is (A-C), IFN-γ
(D), ISGs (E-H) and proinflammatory chemokines/cytokines (I-N) in the dLN at 2.5 dpi of the indicated mice as determined by RT-
qPCR. Data are displayed as mean ± SEM from 5 mice per group in one experiment, which is representative of three similar
experiments. For all, �p<0.05, ��p<0.01, ���p<0.001.
https://doi.org/10.1371/journal.ppat.1008239.g002
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Fig 3. cGAS expression in hematopoietic-derived cells is required for optimal IFN-I and ISG expression in the dLN. (A)
Survival of the indicated mice (B) Expression of Evm003 in the dLN of the indicated mice at 2 dpi as determined by RT-qPCR. Data
are displayed as mean ± SEM from 5 mice per group in one experiment, which is representative of two similar experiments. (C-D)
Virus loads in the spleen (C) and liver (D) of the indicated mice at 7 dpi as determined by plaque assay. Data are displayed as the
mean ± SEM of 5 mice per group. (E-P) As in (B) measuring Ifna4 (E), Ifna-non4 (F), Ifnb1 (G), Ifng (H), Cxcl9 (I), Il6 (J), Il12 (K)
Tnf (L), Ifit3 (M), Irf7 (N) Isg15 (O) and Mx1 (P). Data are displayed as mean ± SEM from 5 mice per group in one experiment,
which is representative of two similar experiments. For all, �p<0.05, ��p<0.01, ���p<0.001, ����p<0.0001.
https://doi.org/10.1371/journal.ppat.1008239.g003
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([60]) and are the principal cells that recruit iMOs, before infected iMOs take over as the
major source of IFN-I in the dLN at later time points [16]. To determine if the increased
viral dissemination in Cgas-/- mice was due to altered recruitment or functionality of
MHC-IIhi DCs, we infected B6 and Cgas-/- mice and analyzed the kinetics of MHC-IIhi DC
recruitment to the dLN and found that the frequency of MHC-IIhi DCs did not change at
1–3 dpi (Fig 4A and 4B) however, there was a significant reduction in total numbers of
MHC-IIhi DCs in the dLN at both 2 and 3 dpi in Cgas-/- mice (Fig 4C). We further con-
firmed that cGAS deficiency did not inherently alter the ability of MHC-IIhi DCs to
migrate to the dLN through the generation of 50:50 mixed B6+Cgas-/-! B6 bone
marrow chimeras and found equivalent frequencies and ratios of MHC-IIhi DCs in the
dLN at 2 dpi (Fig 4D and 4E). Cgas-/- MHC-IIhi DCs appeared functionally intact, at
least with respect to expression of intracellular CXCL9 (S3A Fig), and surface expression
of IFNAR1 (S3B Fig), costimulatory molecules CD40, CD80 and CD86 (S3C–S3E Fig),
and the NKG2D ligands Rae1 and MULT1 which are necessary to active NK cells in the
dLN [17,19] (S3F and S3G Fig). However, at 2.5 dpi with ECTV-dsRED, a significantly
higher proportion of MHC-IIhi DCs were dsRED+ in the dLN of Cgas-/- mice compared to
B6 indicating that Cgas-/- MHC-IIhi DCs are more susceptible to infection (Fig 4F). When
we sorted dsRED+ infected and dsRED- uninfected MHC-IIhi DCs from B6 and Cgas-/-
mice, we found that Cgas-/- MHC-IIhi DCs had significantly higher levels of viral gene
mRNA at 2 dpi, suggesting that cGAS also has a cell-intrinsic role in anti-viral protection
(Fig 4G). Moreover, ECTV-dsRED- MHC-IIhi DCs from Cgas-/- mice had relatively
high levels of viral transcription, likely indicating early infection, before dsRED becomes
fluorescent (Fig 4G). Cgas-/- MHC-IIhi DCs did not upregulate Ifna4 (Fig 4H), Ifna-non4
(S3H Fig) and Ifnb1 (S3I Fig) and the ISGs Ifit3 (Fig 4I), Irf7 (S3J Fig), Isg15 (S3K Fig) and
Mx1 (S3L Fig).
Next, we analyzed whether cGAS deficiency altered iMO accumulation in the dLN. The fre-
quencies of iMO in Cgas-/- and B6 mice were similar at 1–3 dpi (Fig 4J–4K). However, Cgas-/-
mice had a significant reduction in the total number of iMO in the dLN at 2 and 3 dpi (Fig
4L). Yet, Cgas-/- iMOs did not have an intrinsic defect in recruitment to the dLN as determined
in 50:50 mixed B6-Cgas-/- bone marrow chimeras (Fig 4M and 4N). Cgas-/- iMOs were more
susceptible to infection (Fig 4O) and did not upregulate IFN-I (Ifna4 (Fig 4P), Ifna-non4 (S3M
Fig) and Ifnb1 (Fig 1N) or the ISGs (Ifit3 (Fig 4Q), Irf7 (S3O Fig), Isg15 (S3P Fig) and Mx1
(S3Q Fig) but did not differ from B6 iMOs in the frequencies that were CXCL9+ or TNF-α+
(S3R and S3S Fig).
Optimal resistance to ECTV requires a robust NK cell response [19,29]. Our previous work
demonstrated that MHC-IIhi DCs and iMOs play a critical role in the induction and recruit-
ment of circulating NK cells to the dLN [17]. Therefore, we next determined whether Cgas-/-
mice have an altered NK cell response. As with MHC-IIhi DCs and iMOs, Cgas-/- mice had
similar frequencies of NK cells in the dLN at 1–3 dpi (Fig 4R and 4S), but significant reduction
in total numbers of NK cells at 2 and 3 dpi (Fig 4T). Cgas-/- NK cells were significantly more
permissive to infection (Fig 4U), however they were functionally intact, as Cgas-/- mice had no
significant differences in frequency of Granzyme B+, IFN-γ+ and TNF-α+ NK cells in the dLN
compared to B6 controls (S3T–S3V Fig).
We hypothesized that the decreased IFN-I expression and increased infection rate of
MHC-IIhi DCs and iMOs in the dLN of Cgas-/- mice could increase viral-induced cell death
without affecting frequencies of MHC-IIhi DCs and iMOs. In agreement, at 3 dpi, there was a
significant higher frequency of Zombie+ (dead) cells in the dLNs of Cgas-/- than of B6 mice
(Fig 4V).
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Fig 4. Cgas-/- mice have an intrinsic defect in IFN-I expression and accumulation of MHC-IIhi DCs, iMOs and NK cells. (A)
Representative flow cytometry plots of MHC-IIhi DC frequency in the dLN at 2 dpi. (B-C) Calculated frequency (B) and total
numbers (C) of MHC-IIhi DCs in the dLNs of the indicated mice at the indicated dpi. Data are displayed as the mean ± SEM of 12–
15 mice per group combined from three independent experiments. (D) Representative flow cytometry plots of CD45.1 expression on
MHC-IIhi DCs from bone marrow chimeras reconstituted with a 50:50 mix of B6 and Cgas-/- bone marrow cells. (E) Calculated ratio
of CD45.1/Cgas-/- MHC-IIhi DCs from the ndLNs and dLNs of 50:50 mixed bone marrow chimeras at 2 dpi. (F) Frequency of
ECTV-dsRED+MHC-IIhi DCs in the dLN of the indicated mice at 2 dpi. (G-I) Expression of mRNA for the indicated genes: Evm003
(G), Ifna4 (H) and Ifit3 (I) from sorted uninfected and infected MHC-IIhi DCs from the dLN of the indicated mice at 2 dpi. Data are
displayed as mean ± SEM of pooled cells from 6–8 mice per group in one experiment, which is representative of two similar
experiments. P values were calculated based on three technical replicates. (J) Representative flow cytometry plots of CD11b+Gr-1int
iMO in the dLN of the indicated mice at 2.5 dpi. (K-L) As in (B-C) but for iMO. (M-N) As in D-E but for iMO. (O) Frequency of
ECTV-dsRED+ iMO in the dLN of the indicated mice at 2.5 dpi. (P-Q) As in G-K but for sorted infected and uninfected iMO from
the indicated mice at 2 dpi. (R) Representative flow cytometry plots of NK1.1+CD3- NK cells. (S-T) As in D-E but for NK cells. (U)
Frequency of ECTV-dsRED+ NK cells in the dLN of the indicated mice at 2.5 dpi. (T) Calculated frequency of Zombie+ cells in the
dLN at 3 dpi from the indicated mice. For all, �p<0.05, ��p<0.01, ���p<0.001, ����p<0.0001.
https://doi.org/10.1371/journal.ppat.1008239.g004
cGAS in hematopoietic cells mediates resistance to viral disease
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008239 December 26, 2019 10 / 21
Administration of cGAMP to Cgas-/- mice restores IFN-I expression and
resistance to ECTV infection
Binding of DNA to cGAS catalyzes the production of cGAMP which functions as a second
messenger that activates STING [30,31]. Therefore, we tested whether exogenous administra-
tion of cGAMP restores resistance to mousepox to Cgas-/- mice. All Cgas-/- mice that received
cGAMP in the footpad prior to infection (cGAMP+ECTV) survived (Fig 5A) with a concomi-
tant significant reduction in viral replication in the dLN at 2 dpi (Fig 5B). To determine
whether the decrease in viral replication was due to cGAMP-mediated IFN-I induction in the
dLN, we measured IFN-I transcripts in the dLN at 2 dpi, however, there was a drastic reduc-
tion in Ifna4 (Fig 5C) Ifna-non4 (Fig 5D) and Ifnb1 (Fig 5E).). Although cGAMP administra-
tion increased the recruitment of MHC-IIhi DCs to the dLN of both B6 and Cgas-/- mice (Fig
5F), there was a significant decrease in iMOs (Fig 5G), which accounted for the decrease in
IFN-I. These results suggested that cGAMP decreases viral replication in the skin of the foot-
pad and curbs (but does not prevent) spread to the dLN. In agreement, at 2 dpi, there was sig-
nificantly lower viral replication in the skin of the footpad in cGAMP+ECTV mice (Fig 5H).
Moreover, cGAMP+ECTV induced a strong increase in Ifna4, Ifna-non4, and Ifnb1 expression
in the skin of the footpad of B6 and Cgas-/- mice (Fig 5I–5K). Furthermore, cGAMP+ ECTV
restored the expression of the ISGs Ifit3, Irf7, Isg15 and Mx1 in the skin (Fig 5L and 5M), there-
fore, potentially contributing to diminishing viral replication in the skin with subsequent
decrease in dissemination to the dLN.
cGAMP-mediated resistance to ECTV is mostly dependent on IRF7
It is well-established that pathogen-recognition by cGAS catalyzes the formation of cGAMP
which activates STING [28,32]. While STING has been demonstrated to activate not only IRF3
but also IRF7 [33,34], IRF3 has been overwhelmingly utilized to describe the canonical path-
way of cGAS-STING signaling. However, we have previously demonstrated that IRF7, but not
IRF3, is required for T1-IFN expression in the dLN and resistance to ECTV [16]. Therefore,
we investigated whether IRF7 is required for the anti-ECTV effects of cGAMP. We found that
cGAMP administration to Irf7-/- mice did not decrease ECTV gene expression in the skin (Fig
6A) or dLN at 2 dpi (Fig 6B). Also, ECTV-infected Irf7-/- mice receiving cGAMP and ECTV
upregulated transcription of Ifna4 (Fig 6C and 6F) and Ifnb1 (Fig 6D and 6G) but not of Ifna-
non4 (Fig 6E and 6H) in the skin and dLN. IRF7 deficiency did not alter expression levels of
proinflammatory cytokines and chemokines in the skin and dLN after ECTV or cGAMP
+ECTV (S4A–S4H Fig) indicating that the main role of IRF7 during ECTV infection is in
IFN-I but not in pro-inflammatory cytokine induction. Furthermore, despite the Ifna4 and
Ifnb1 increase, cGAMP and cGAMP+ECTV did not upregulate ISGs in the skin (Fig 6I–6L) of
Irf7-/- mice. Also, the seemingly increased survival of Irf7-/- mice treated with cGAMP in sur-
vival as compared to untreated controls, did not reach statistical significance (Fig 6M).
cGAMP-mediated ISG induction is dependent on IFNAR1
The induction of ISGs requires IFN-I binding and signaling through IFNAR1 to induce an
anti-viral state [6,7]. After ECTV infection, Ifnar1-/- mice had significantly higher levels of
ECTV gene transcription than B6 controls in the skin of the footpad and in the dLN at 2 dpi
whether receiving cGAMP or not (Fig 7A and 7B). Furthermore, while IFN-I expression in the
skin (Fig 7C–7E) and dLN (Fig 7F–7H) was unaffected by the absence of IFNAR1, Ifnar1-/-
mice were unable to upregulate ISGs (Fig 7I–7L). IFNAR1 deficiency also did not alter
proinflammatory cytokine and chemokine expression in the skin (S5A–S5D Fig) or dLN
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Fig 5. Administration of cyclic GMP-AMP (cGAMP) to Cgas-/- mice restores IFN-I expression and resistance to
ECTV infection. (A) Survival of the indicated mice. (B-E) Expression of Evm003 (B), Ifna4 (C), Ifna-non4 (D) and
Ifnb1 (E) in the dLN of the indicated mice at 2 dpi as determined by RT-qPCR. Data are displayed as mean ± SEM
from 5 mice per group in one experiment, which is representative of three independent experiments. (F-G) Calculated
total numbers of MHC-IIhi DCs (E) and iMO (F) in the dLN of the indicated mice at 2 dpi. Data are displayed as
mean ± SEM with 12–15 mice per group combined from three similar, independent experiments. (H-O) Expression of
Evm003 (H), Ifna4 (I), Ifna-non4 (J), Ifnb1 (K), Ifit3 (L), Irf7 (M), Isg15 (N) and Mx1 (O) in the skin of the indicated
mice at 2 dpi as determined by RT-qPCR. Data are displayed as mean ± SEM from 5 mice per group in one
experiment, which is representative of three similar, independent experiments. For all, �p<0.05, ��p<0.01,
���p<0.001, ����p<0.0001.
https://doi.org/10.1371/journal.ppat.1008239.g005
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(S5E–S5H Fig) uncoupling IFN-I and proinflammatory cytokine induction. Moreover,
cGAMP did not rescue Ifnar1-/- mice from lethal mousepox (Fig 7M). These data indicate a
critical role for IFN-I signaling in cGAMP-mediated resistance to ECTV.
Discussion
Our lab and others have been redefining the paradigm of the LN as not only an important site
for lymphocyte priming but as an essential checkpoint to curb viral dissemination. Resistance
to mousepox requires a multitude of components of the innate immune system, including a
strong NK cell and IFN-I response [16,19,29]. The early accumulation of NK cells in the dLN
is required for restriction of ECTV lympho-hematogenous spread and protection from lethal
mousepox [19,29]. Moreover, we have recently dissected the pathway in which migratory
DCs, group1 innate lymphoid cells (ILCs, mostly NK cells) and iMO collaborate to recruit
Fig 6. cGAMP-mediated resistance to ECTV is mostly dependent on IRF7. (A-B) Expression of Evm036 in the skin (A) and dLN
(B) in the skin of B6 and Irf7-/- mice at 2 dpi as determined by RT-qPCR. Data are displayed as mean ± SEM from 5 mice per group
in one experiment, which is representative of three independent experiments. (C-L) As in (A-B) but for IFN-I expression in the skin
(C-E), dLN (F-H) and ISGs in the skin (I-L). (M) Survival of the indicated mice. For all, �p<0.05, ��p<0.01, ���p<0.001,
����p<0.0001.
https://doi.org/10.1371/journal.ppat.1008239.g006
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circulating NK cells to the dLN [17]. IFN-I exert a wide variety of pleotropic biological effects
through the upregulation of ISGs, all of which collectively work to resist and control infection
[6]. The importance of IFN-I in acute viral infections is clearly demonstrated through IFNAR1
deficiency or blocking experiments, which predominantly increases viral replication, dissemi-
nation and lethality even for many non-species-specific viruses such as Zika virus, West Nile
virus or Dengue Virus in mice [8–10,35–38]. After ECTV infection, MHC-IIhi DCs migrate to
the dLN and are responsible for the very early expression of IFN-I and the chemokines CCL2
and CCL7 that recruit iMO [16]. Notably, TLR9 and MyD88 are indirectly necessary to bring
iMO to the dLN and for resistance to mousepox. However, they are not directly necessary for
IFN-I production [16]. Instead, once infected, the incoming iMO use STING signaling to IRF7
and NF-κB to induce the expression of IFN-α and IFN-β respectively, thereby becoming the
main source of IFN-I in the dLN [16]. However, the mechanisms of IFN-I dependent
Fig 7. cGAMP-mediated protection against ECTV is dependent on IFNAR1. (A-B) Expression of Evm003 in the skin (A) and
dLN (B) of B6 and Ifnar1-/- mice at 2 dpi as determined by RT-qPCR. (C-H) Expression of IFN-I in the skin (C-E) and dLN (F-H) of
B6 and Ifnar1-/- mice at 2 dpi as determined by RT-qPCR. (I-L) Expression of ISGs in the skin of B6 and Ifnar1-/- mice at 2 dpi as
determined by RT-qPCR. Data are displayed as mean ± SEM from 5 mice per group in one experiment, which is representative of
two independent experiments. (M) Survival of the indicated mice. For all, �p<0.05, ��p<0.01, ���p<0.001, ����p<0.0001.
https://doi.org/10.1371/journal.ppat.1008239.g007
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resistance and the identity of the PRR upstream of STING that mediate IFN-I induction
against acute ECTV infection remained unclear.
Identifying the major cytosolic DNA PRR for IFN-I induction by ECTV is important
because ECTV is the archetype for a large number of viruses relevant to animal and human
health that utilize the lympho-hematogenous route of dissemination. STING is a critical adap-
tor protein downstream of over 10 different cytosolic DNA sensors [39]. We recently dis-
counted DAI as the major PRR for ECTV [16]. Another main candidate as an ECTV PRR was
IFI204, the murine ortholog for the human IFI16 and member of the AIM2-like receptor fam-
ily, because it was among the few genes that mapped to Rmp-4 on chromosome 1 that confers
resistance to ECTV [22]. Furthermore, IFI204 has been shown to be important in interacting
with ASC and procaspase-1 to form the inflammasome and subsequent IL-1β release [24] as
well as induction of IFN-β expression in herpesvirus [24], L. monocytogenes [40], F. novicida
[23], and M. bovis infection [41]. Our results show, however, that IFI204 is not essential for
resistance to mousepox because all Ifi204-/- mice survived infection, had similar viral titers in
the liver as B6 mice, and their IFN-I expression in the dLN was the same as in B6 mice. Yet,
while it appears that IFI204 is not the major PRR for IFN-I induction during ECTV infection,
it may still play secondary role, or may have some role in inflammasome activation or a cell-
death pathway that contribute to ECTV control. In support, Ifi204-/- had slightly higher virus
titers in the spleen than B6 mice.
The cGAS-STING pathway mediates IFN-I production in vitro in mouse cDCs [42], macro-
phages and fibroblasts [28], and in human embryonic kidney 293 cells [43] after infection with
the OPVs VACV or MVA. Moreover, cGAS-STING-dependent IFN-I production has been
implicated in numerous infection models including herpes simplex virus [28,44], adenovirus
[45], cytomegalovirus [46], Kaposi’s sarcoma-associated herpesvirus [47] as well as retrovi-
ruses including HIV-1 and HIV-2 [48]. Yet, the role of cGAS in protection against viruses that
disseminate through the natural route of infection in natural hosts had not been studied. Very
recently, Cheng and colleagues demonstrated that cGAS-STING-IRF3 is required for optimal
induction of IFN-β in various cell types [18]. Furthermore, Cheng et al. showed that cGAS is
necessary for increased survival to mousepox at 106 pfu but not to 3,000 pfu ECTV [18]. Our
present study partially confirms some of Cheng et al. results and significantly extends them.
Different to Cheng et al., we found that Cgas-/- mice were highly susceptible to lethal mousepox
after infection with only 3,000 pfu ECTV. The reason for the difference between labs is
unclear but may be due to differences in animal facilities such as, for example, changes in the
microbiome.
Analysis of various transcripts in the dLN revealed that Cgas-/- deficiency resulted in drasti-
cally reduced expression of IFN-I and downstream ISGs, which is the likely reason why viral
replication and spread was increased, Yet, IFN-I and ISG induction was not completely ablated
in the dLN of Cgas-/- mice. This could be attributed to two reasons: 1) While cGAS deficiency
essentially completely ablates IFN-I expression in iMO and MHC-IIhi DCs, there could be
other immune cell types that produce IFN-I independently of cGAS. 2) Other cytosolic DNA
sensors may recognize ECTV and induce some IFN-I. While DAI [16] or IFI204 are not
required for resistance against ECTV, they may still partially contribute to the IFN-I response.
Notably, cGAS deficiency did not affect the transcription of proinflammatory cytokines/che-
mokines in the dLN indicating that their induction is fully dependent on other sensing path-
ways, such as TLR9, and that cGAS is likely dedicated to the induction of IFN-I and ISGs.
Thus, the need for cGAS reinforces the importance of IFN-I in resistance to mousepox and the
notion that cGAS can play a pivotal role in ISG induction after viral infection [49].
The role of cGAS in the hematopoietic vs non-hematopoietic compartment in anti-viral
control is unclear. Li et al. demonstrated that Cgas-/- mouse fibroblasts failed to produce IFN-I
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[28]. Furthermore, cGAS plays a role in human keratinocytes sensing of HSV-1 and VACV
[25] and the anti-tumor response in stromal cells [50]. However, we have shown that during
ECTV infection, IFN-I is mainly produced by BMD MHC-IIhi DCs and iMO, suggesting that
the critical cells expressing cGAS should be BMD. Using bone marrow chimeras, we show that
B6!B6 and B6!Cgas-/- mice survived mousepox with significantly lower viral gene expres-
sion in the dLN and infectious virus in the liver than B6!Cgas-/- and Cgas-/-!Cgas-/-, which
succumbed to mousepox. This demonstrates that cGAS in hematopoietic cells but not in other
tissues is essential for resistance to mousepox and virus control. Interestingly, B6! cGas-/-
had significantly more virus in the liver than B6!B6 mice and Cgas-/-!Cgas-/- had more
virus in the liver than Cgas-/-!B6 mice, suggesting a minor contribution in virus control by
the parenchymal cells such as hepatocytes, or by radio-resistant, self-sustaining, innate
immune cells derived from the yolk sac, such as Langerhans and/or Kupffer cells [51,52]. In
support, we have found that Langerhans cells are the main subset of MHC-IIhi DCs that are
responsible for the accumulation of iMO in the dLN [60]. Consistent with the survival data
and the results with plain Cgas-/- mice, however, IFN-I and ISG induction was significantly
higher in B6!B6 and B6!Cgas-/- compared to Cgas-/-!B6 and Cgas-/-!Cgas-/- mice, sug-
gesting that cells generated in the bone marrow are the main IFN-I producers and required for
ISG expression.
Binding of DNA activates cGAS by inducing a conformational change in the cGAS active
site. Activated cGAS catalyzes the synthesis of cyclic GMP-AMP (cGAMP), which functions as
a second messenger for IFN-I induction by activating STING [12,28,31]. cGAMP has been
used as an adjuvant to boost antigen-specific T cell responses [28] and in cutaneous vaccina-
tion against influenza [53], mucosal vaccination [54], and in various tumor models [32,55,56].
We found that local administration of exogenous cGAMP in the footpad bypassed cGAS defi-
ciency and fully rescued Cgas-/- mice from lethal mousepox. Mechanistically, cGAMP primed
the skin microenvironment to induce IFN-I and ISG transcription after ECTV infection,
which reduced the level of local viral replication and, consequently, decreased viral dissemina-
tion to the dLN. Thus, the innate responses in the dLN were drastically decreased. Notably,
despite that some viral dissemination still occurred, the mice were protected from lethal mou-
sepox. These data indicates that early virus sensing by BMD cells and the subsequent IFN-I
response at the initial site of entry may serve as a critical checkpoint to decrease lympho-hema-
togenous viral dissemination and resist systemic lethal disease. Notably, ECTV infection alone
induced less IFN-I mRNA in the skin than ECTV+cGAMP. This could be due to the many
immune evasion molecules encoded by ECTV and other poxviruses [57]. For example, VACV
inhibits the activation of STING, and Cowpox and ECTV inhibit STING dimerization in vitro
[58]. Also of interest, cGAMP alone also induced little IFN-I suggesting that in addition to
cGAMP production by cGAS, other virus-sensing mechanisms are required for IFN-I expres-
sion. Surprisingly, cGAMP administration induced a stronger IFN-I response in the skin of
Cgas-/- than in B6 mice. Our experiments provide a snapshot of the differential IFN-I response
in the skin of B6 and Cgas-/- at 2 dpi. While the importance of these differences remain
unknown, our data suggest that cGAS may provide a negative feedback signal in the skin,
which contains a complex microbiome. Future experiments will focus on the administration
of cGAMP at different time points pre- and post-infection, as well as different routes of admin-
istration, to assess how cGAMP modulates the innate and adaptive responses and evaluate
cGAMP’s efficacy as an effective adjuvant in anti-viral therapeutics.
Following cGAMP binding, the endoplasmic-reticulum (ER)-membrane adaptor STING
[12] becomes activated and traffics to the ER-Golgi intermediate compartment and the Golgi
apparatus, to activate TANK binding kinase 1 (TBK1). It is commonly described that activated
TBK1 phosphorylates IRF3 or IKK which then phosphorylates NF-kB [12]. Activated IRF3,
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NF-kB and other transcription factors traffic to the nucleus to bind to the promoters and
induce the expression of IFN-I and proinflammatory cytokines including IL-6, TNF, and IL-
1β [12]. While STING was originally shown to activate not only IRF3 but also IRF7 [33] and
IRF3 and IRF7 have been shown to have non-redundant roles in different infection models
[59], IRF3 is generally described in reviews as the main IRF downstream of cGAS and STING
[28]. Cheng et al. showed that transcription of Ifnb1 by murine L929 and RAW264.7 cells
infected with ECTV required cGAS-STING-IRF3. Yet, they did not confirm their results in
IRF3 or IRF7 deficient mice in vivo [18]. In previous work we showed that the expression of
IFN-α in the dLN is dependent on IRF7 and not IRF3 and that IRF7 but not IRF3 is required
for resistance to mousepox [16]. In agreement, here we found that cGAMP did not promote
significant survival of Irf7-/- mice to mousepox, did not decrease viral replication in the skin,
and did not promote Ifna-non4 expression in the skin which emphasizes that cGAS-STIN-
G-IRF7 is the predominant IFN-I-inducing pathway in the skin and dLN during ECTV
infection.
Finally, we showed that ECTV+ cGAMP failed to prevent viral replication and lethal mou-
sepox in Ifnar1-/- mice. Analysis of gene transcription showed that Ifnar1-/- mice upregulated
IFN-I and proinflammatory cytokine genes in both the skin and dLN to higher levels than B6
mice probably due to the increased virus loads. Yet, Ifnar1-/- mice did not upregulate ISGs.
These results indicate that the main mechanism of action of cGAMP is through the induction
of ISGs by IFN-I.
In summary, here we demonstrate that cGAS-mediated IFN-I and ISG induction in the
hematopoietic compartment is required for protection against ECTV. We also show that
increased susceptibility due to cGAS deficiency can be overridden by local cGAMP adminis-
tration. Mechanistically, cGAMP decreases viral replication in the skin and lympho-hematoge-
nous viral dissemination by activating ISGs via a pathway that requires IRF7, IFN-I and
IFNAR. Together, these results highlight the importance of cGAS as the major cytosolic DNA
sensor to ECTV and provide important insights into the innate mechanism that can curb viral
dissemination from the initial site of infection, and its importance for overall virus control.
Supporting information
S1 Fig. CpG does not induce IFN-I and ISG expression in the dLN of B6 or Cgas-/- mice. B6
or Cgas-/- mice were either infected with 3,000 pfu ECTV or given 25 ug CpG in the footpad.
LNs were harvested at 2 dpi. Data are displayed as mean ± SEM from 5 mice per group in
experiment, which is representative of two similar experiments. For all, �p<0.05.
(TIF)
S2 Fig. Efficiency of B6-Cgas-/- BM chimera reconstitution. (A) Total cellularity of the naïve
contralateral LNs of B6-Cgas-/- chimeric mice. (B-G) Total numbers of the indicated immune
cell subtype in the naïve contralateral LNs of B6-Cgas-/- chimeric mice. Data are displayed as
mean ± SEM with 10–15 mice per group combined from three similar, independent experi-
ments.
(TIF)
S3 Fig. Cgas-/- mice have an intrinsic defect in IFN-I expression and accumulation of
MHC-IIhi DCs, iMOs and NK cells. (A) Frequency of CXCL9+MHC-IIhi DCs in the dLN of
the indicated mice at 2.5 dpi. (B-G) MFI of IFNAR1 (B), costimulatory molecules CD40 (C),
CD80 (D) and CD86 (E), and NKG2D ligands Rae1 (G) and MULT1 (G). Data are displayed
as mean ± SEM of 10–12 mice per group combined from three independent experiments.
(H-L) Expression of mRNA for Ifna-non4 (H), Ifnb1 (I), Irf7 (J), Isg15 (K) and Mx1 (L) from
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sorted uninfected and infected MHC-IIhi DCs from the dLN of the indicated mice at 2 dpi.
Data are displayed as mean ± SEM of pooled cells from 6–8 mice per group in one experiment,
which is representative of two similar experiments. P values were calculated based on three
technical replicates. (M-Q) As in (H-L) but for iMO. (R-S) Frequency of CXCL9+ and TNF-α+
iMO in the dLN at 2.5 dpi during ECTV infection. (T-V) Frequencies of Granzyme B+ (T),
IFN-γ+ (U), and TNF-α+ (V) NK cells in the dLN of the indicated mice at 2.5 dpi. For all,
�p<0.05, ��p<0.01, ���p<0.001, ����p<0.0001.
(TIF)
S4 Fig. Proinflammatory cytokine and chemokine expression in Irf7-/- mice. (A-H) Expres-
sion of proinflammatory cytokines and chemokines in the skin (A-D) and dLN (E-H) of B6
and Irf7-/- mice at 2 dpi with or without cGAMP administration. Data are displayed as
mean ± SEM from 5 mice per group in one experiment, which is representative of three inde-
pendent experiments. For all, �p<0.05, ��p<0.01, ���p<0.001, ����p<0.0001.
(TIF)
S5 Fig. Proinflammatory cytokine and chemokine expression in Ifnar1-/- mice. (A-H)
Expression of proinflammatory cytokines and chemokines in the skin (A-D) and dLN (E-H)
of B6 and Ifnar-/- mice at 2 dpi with or without cGAMP administration. Data are displayed as
mean ± SEM from 5 mice per group in one experiment, which is representative of three inde-
pendent experiments. For all, �p<0.05, ��p<0.01, ���p<0.001, ����p<0.0001.
(TIF)
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